Literature DB >> 7695672

Pre-hospital opiate and aspirin administration in patients with suspected myocardial infarction.

H R Wyllie1, F G Dunn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7695672      PMCID: PMC2539681          DOI: 10.1136/bmj.308.6931.760a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  1 in total

Review 1.  The use of aspirin in ischemic heart disease.

Authors:  J E Willard; R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  1992-07-16       Impact factor: 91.245

  1 in total
  8 in total

1.  Aspirin and suspected myocardial infarction: a life-saving treatment we too often forget.

Authors:  R D Hardern
Journal:  J Accid Emerg Med       Date:  1995-12

2.  Aspirin in acute myocardial infarction.

Authors:  C Bradshaw; J H Parr; M P Eccles; P Whitty; E Murray; W Broderick; H L Courtenay; J Royle
Journal:  Br J Gen Pract       Date:  1996-04       Impact factor: 5.386

3.  Aspirin and acute myocardial infarction: clarifying the message.

Authors:  J Deeks; I Watt; N Freemantle
Journal:  Br J Gen Pract       Date:  1995-08       Impact factor: 5.386

4.  Early management of myocardial infarction. The challenge for the GPs is to change.

Authors:  A D Short; B West
Journal:  BMJ       Date:  1994-04-30

Review 5.  Aspirin for myocardial infarction. Clinical pharmacokinetic considerations.

Authors:  F Bochner; J V Lloyd
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

6.  Suspected myocardial infarction and the GP.

Authors:  P Herbert
Journal:  BMJ       Date:  1994-03-19

Review 7.  Is aspirin underused in myocardial infarction?

Authors:  J M Arnau; A Agustí
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

8.  One-year prospective study of cases of suspected acute myocardial infarction managed by urban and rural general practitioners.

Authors:  A W Murphy; D McCafferty; J Dowling; G Bury
Journal:  Br J Gen Pract       Date:  1996-02       Impact factor: 5.386

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.